Stephanie Okey, Director at PTC THERAPEUTICS, INC. (PTCT), sold 6,333 shares at $63.38 ($401K) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Scheduled sale ($401k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CRNX | SELL | 2026-03-04 | $119K | — | Filing → |
| PTCT | SELL | 2025-03-17 | $270K | — | Filing → |
| CRNX | SELL | 2024-04-02 | $812K | — | Filing → |